These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3729357)

  • 1. Antibacterial activity of GO 10213, a nitroimidazole derivative.
    Hof H; Ströder J
    Antimicrob Agents Chemother; 1986 May; 29(5):953-4. PubMed ID: 3729357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.
    Hof H; Sticht-Groh V; Müller KM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):332-3. PubMed ID: 6927288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.
    Hof H; Rieffert M; Sticht-Groh V; Zak O; Schweizer EH
    Antimicrob Agents Chemother; 1984 Oct; 26(4):498-500. PubMed ID: 6517542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial, antimycotic and trichomonicidal activity of a new nitroimidazole (EU 11100).
    Dubini F; Riviera L; Cocuzza C; Bellotti MG
    J Chemother; 1992 Dec; 4(6):342-6. PubMed ID: 1287136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of 2-amino-4(2-ethynyl-1-methyl-5-nitroimidazole)-pyrimidine, a metronidazole derivative with antitrichomonad activity.
    Bertolini A; Castelli M; Poggioli R
    Experientia; 1974 Jul; 30(7):757-8. PubMed ID: 4211237
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.
    Hof H; Ströder J; Buisson JP; Royer R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):679-83. PubMed ID: 3800344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.
    Hof H; Sticht-Groh V
    Infection; 1984; 12(1):36-9. PubMed ID: 6706411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].
    Hof H; Müller KM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):265-71. PubMed ID: 6299027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutagenicity of a series of 25 nitroimidazoles and two nitrothiazoles in Salmonella typhimurium.
    Cantelli-Forti G; Aicardi G; Guerra MC; Barbaro AM; Biagi GL
    Teratog Carcinog Mutagen; 1983; 3(1):51-63. PubMed ID: 6132457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.
    Malagoli M; Rossi T; Baggio A; Zandomeneghi G; Zanca A; Casolari C; Castelli M
    Pharmacol Res; 2002 Nov; 46(5):469-72. PubMed ID: 12419652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the antitrichomonal activity of 5-nitroimidazole derivatives by hydrogen peroxide.
    Mattana A; Juliano C; Picci V; Franconi F; Cappuccinelli P
    New Microbiol; 1993 Oct; 16(4):359-65. PubMed ID: 8264426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activities of nitrothiazole derivatives.
    Hof H; Zak O; Schweizer E; Denzler A
    J Antimicrob Chemother; 1984 Jul; 14(1):31-9. PubMed ID: 6384174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Olsson-Liljequist B; Nord CE
    Scand J Infect Dis Suppl; 1981; 26():42-5. PubMed ID: 6941455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro studies of two 5-nitroimidazole derivatives.
    Castelli M; Malagoli M; Ruberto AI; Baggio A; Casolari C; Cermelli C; Bossa MR; Rossi T; Paolucci F; Roffia S
    J Antimicrob Chemother; 1997 Jul; 40(1):19-25. PubMed ID: 9249200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of tinidazole on T. vaginalis in vitro].
    Savoia D; Martinetto P; Pugliese A
    G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic activities of nitrothiazole derivatives in experimental infections with Salmonella typhimurium and Bacteroides fragilis.
    Hof H; Eisenbarth B; Denzler A; Zak O; Schweizer E
    J Antimicrob Chemother; 1985 Aug; 16(2):205-10. PubMed ID: 3905749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.
    Goldstein EJ; Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1978 Oct; 14(4):609-13. PubMed ID: 718156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mutagenic action of nitroimidazoles. I. Metronidazole, nimorazole, dimetridazole and ronidazole.
    Voogd CE; Van der Stel JJ; Jacobs JJ
    Mutat Res; 1974 Dec; 26(6):483-90. PubMed ID: 4610373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.